103 related articles for article (PubMed ID: 16611667)
1. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis.
Nelson JC; Jiang XC; Tabas I; Tall A; Shea S
Am J Epidemiol; 2006 May; 163(10):903-12. PubMed ID: 16611667
[TBL] [Abstract][Full Text] [Related]
2. Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis.
Inoue K; Goldwater D; Allison M; Seeman T; Kestenbaum BR; Watson KE
Hypertension; 2020 Jul; 76(1):113-120. PubMed ID: 32418495
[TBL] [Abstract][Full Text] [Related]
3. Subclinical atherosclerosis: More data - More insights into prevention.
Drexel H; Festa A
Atherosclerosis; 2024 Jun; 393():117561. PubMed ID: 38688750
[No Abstract] [Full Text] [Related]
4. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis.
Yeboah J; McNamara C; Jiang XC; Tabas I; Herrington DM; Burke GL; Shea S
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):628-33. PubMed ID: 20032291
[TBL] [Abstract][Full Text] [Related]
5. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Implications of Sphingomyelin Presence in Biological Membranes.
Kikas P; Chalikias G; Tziakas D
Eur Cardiol; 2018 Aug; 13(1):42-45. PubMed ID: 30310470
[TBL] [Abstract][Full Text] [Related]
7. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.
Würtz P; Havulinna AS; Soininen P; Tynkkynen T; Prieto-Merino D; Tillin T; Ghorbani A; Artati A; Wang Q; Tiainen M; Kangas AJ; Kettunen J; Kaikkonen J; Mikkilä V; Jula A; Kähönen M; Lehtimäki T; Lawlor DA; Gaunt TR; Hughes AD; Sattar N; Illig T; Adamski J; Wang TJ; Perola M; Ripatti S; Vasan RS; Raitakari OT; Gerszten RE; Casas JP; Chaturvedi N; Ala-Korpela M; Salomaa V
Circulation; 2015 Mar; 131(9):774-85. PubMed ID: 25573147
[TBL] [Abstract][Full Text] [Related]
8. Biological functions of sphingomyelins.
Slotte JP
Prog Lipid Res; 2013 Oct; 52(4):424-37. PubMed ID: 23684760
[TBL] [Abstract][Full Text] [Related]
9. Lipid rafts as a membrane-organizing principle.
Lingwood D; Simons K
Science; 2010 Jan; 327(5961):46-50. PubMed ID: 20044567
[TBL] [Abstract][Full Text] [Related]
10. Sphingomyelin breakdown and cell fate.
Testi R
Trends Biochem Sci; 1996 Dec; 21(12):468-71. PubMed ID: 9009829
[TBL] [Abstract][Full Text] [Related]
11. The impacts of dietary sphingomyelin supplementation on metabolic parameters of healthy adults: a systematic review and meta-analysis of randomized controlled trials.
Li CZ; Wu LM; Zhu CX; Du HY; Chen GX; Yang F
Front Nutr; 2024; 11():1363077. PubMed ID: 38463938
[TBL] [Abstract][Full Text] [Related]
12. Diet-Induced Severe Hyperhomocysteinemia Promotes Atherosclerosis Progression and Dysregulates the Plasma Metabolome in Apolipoprotein-E-Deficient Mice.
Andrews SG; Koehle AM; Paudel D; Neuberger T; Ross AC; Singh V; Bottiglieri T; Castro R
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337615
[TBL] [Abstract][Full Text] [Related]
13. Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes.
Sojo L; Santos-González E; Riera L; Aguilera A; Barahona R; Pellicer P; Buxó M; Mayneris-Perxachs J; Fernandez-Balsells M; Fernández-Real JM
Antioxidants (Basel); 2023 May; 12(5):. PubMed ID: 37237999
[TBL] [Abstract][Full Text] [Related]
14. The lipidomes of
Staab TA; McIntyre G; Wang L; Radeny J; Bettcher L; Guillen M; Peck MP; Kalil AP; Bromley SP; Raftery D; Chan JP
Aging (Albany NY); 2023 Feb; 15(3):650-674. PubMed ID: 36787434
[TBL] [Abstract][Full Text] [Related]
15. Glycosphingolipids in Diabetes, Oxidative Stress, and Cardiovascular Disease: Prevention in Experimental Animal Models.
Balram A; Thapa S; Chatterjee S
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499769
[TBL] [Abstract][Full Text] [Related]
16. Identification of circulating metabolites associated with wooden breast and white striping.
Lake JA; Yan Y; Dekkers JCM; Qiu J; Brannick EM; Abasht B
PLoS One; 2022; 17(9):e0274208. PubMed ID: 36156596
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics of Arterial Stiffness.
Paapstel K; Kals J
Metabolites; 2022 Apr; 12(5):. PubMed ID: 35629874
[TBL] [Abstract][Full Text] [Related]
18. De Novo Sphingolipid Biosynthesis in Atherosclerosis.
Park TS; Devi S; Sharma A; Kim GT; Cho KH
Adv Exp Med Biol; 2022; 1372():31-46. PubMed ID: 35503172
[TBL] [Abstract][Full Text] [Related]
19. Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis.
Longo L; Rampelotto PH; Filippi-Chiela E; de Souza VEG; Salvati F; Cerski CT; da Silveira TR; Oliveira CP; Uribe-Cruz C; Álvares-da-Silva MR
World J Hepatol; 2021 Dec; 13(12):2052-2070. PubMed ID: 35070008
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Moderate Alcohol Consumption on Circulating Metabolites and Gut Microbiota in Patients With Coronary Artery Disease.
Zhao X; Zhou R; Li H; Fan Y; Sun Y; Hu X; Zhang S
Front Cardiovasc Med; 2021; 8():767692. PubMed ID: 34796220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
